Used in pharmaceutical research as a potent and selective inhibitor of certain kinase enzymes involved in inflammatory and immune responses. Shows promise in the development of treatments for autoimmune diseases such as rheumatoid arthritis and psoriasis due to its ability to modulate signaling pathways like JAK-STAT. Also investigated for oncology applications, particularly in cancers driven by dysregulated tyrosine kinase activity. Its structure allows for high cell permeability and target binding affinity, making it a valuable scaffold in drug design. Currently utilized primarily in preclinical studies to evaluate efficacy, pharmacokinetics, and toxicity profiles.